Danaher Corporation vs Live Nation Entertainment, Inc. — how do they compare? Danaher Corporation trades at $207.45 (market cap $145.83B), while Live Nation Entertainment, Inc. trades at $183.14 (market cap $42.71B). The key difference: Danaher Corporation is far larger — about 3.4× Live Nation Entertainment, Inc.'s market cap, and Danaher Corporation pays a 0.77% dividend while Live Nation Entertainment, Inc. pays none. Which is the better fit depends on your goals.
| DHR | LYV | |
|---|---|---|
Market Cap | $145.83B | $42.71B |
Sector | Health | Industrials |
52-Week High | $242.05 | $186.59 |
52-Week Low | $161.91 | $125.61 |
Enterprise Value | $168.04B | $44.92B |
Dividend Yield | 0.77% | — |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $209.26, up 2.2% today, with strong technical momentum as the price sits above key support levels. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.92. Fundamentals show robust profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst sentiment is overwhelmingly positive with 69% buy ratings and a $202.33 consensus price target. Recent news highlights the acquisition of Masimo and new product launches in its biotechnology segment.
The outlook for DHR remains favorable driven by earnings beats and strategic acquisitions, but investors face risks from elevated valuation multiples and potential macroeconomic headwinds. The stock's current technical overbought condition suggests near-term consolidation may occur, yet long-term growth prospects in life sciences support a bullish stance. Key watch points include Q3 2026 earnings results and integration progress of recent acquisitions.
Live Nation (LYV) trades at $185.71, up 0.58% with strong bullish technical signals from moving averages. The stock shows mixed fundamentals with a high P/E of 117.49 but beat Q2 2026 earnings expectations. Revenue growth remains robust at $25.2B in 2025, though net margins are thin at 0.51%. Recent insider sales and legal concerns create headwinds despite analyst optimism.
Outlook remains cautiously optimistic with 87% analyst buy ratings and a $209.54 price target suggesting 13% upside. Key risks include elevated valuation, debt levels, and regulatory scrutiny. The company's dominant live events position and strong demand provide growth catalysts, but execution on cost management will be critical for profitability improvement.
Trailing returns across standard periods
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →